Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Finance Receivables9.79M93.94%
Pharmaceutical Development and Other631K6.06%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States37.76M100.00%